2019 annual financial data
ImmunityBio 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was -353,741.86%.
Operating income was -66,907,000 USD and net income was -65,789,000 USD.
Operating cash flow was -152,109,000 USD.
Get free ImmunityBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 43,000 USD
- Operating income
- -66,907,000 USD
- Net income
- -65,789,000 USD
- Operating cash flow
- -152,109,000 USD